designer491
- Teva Pharmaceutical (NYSE:TEVA) announced that it will divest Teva-Takeda, its business venture in Japan, to JKI Co., established by the fund managed and operated by private equity firm J-Will Partners Co., Ltd.
- As per the deal, all shares of Teva Takeda Pharma Limited and its
